Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA FLOW CYTOMETRY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES
5.2 RESTRAINTS
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS
5.2.2 LIMITATIONS OF FLOW CYTOMETRY
5.2.3 LACK OF SKILLED PROFESSIONALS
5.3 OPPORTUNITIES
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.4 DEVELOPING A PIPELINE OF STEM CELL RESEARCH
5.4 CHALLENGES
5.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT
6 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 REAGENTS AND CONSUMABLES
6.2.1 DYE
6.2.2 ANTIBODIES
6.2.3 BEADS
6.2.4 OTHERS
6.3 FLOW CYTOMETRY INSTRUMENTS
6.3.1 CELL ANALYZERS
6.3.1.1 CELL ANALYZERS, BY TYPE
6.3.1.1.1 IMAGING FLOW CYTOMETERS
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS
6.3.1.2 CELL ANALYZERS, BY MODALITY
6.3.1.2.1 BENCHTOP
6.3.1.2.2 STANDALONE
6.3.2 CELL SORTERS
6.3.2.1 BENCHTOP
6.3.2.2 STANDALONE
6.4 ACCESSORIES
6.4.1 FILTERS
6.4.2 DETECTORS
6.4.3 OTHERS
6.5 SERVICES
6.6 SOFTWARE
7 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 CELL-BASED FLOW CYTOMETRY
7.3 BEAD-BASED FLOW CYTOMETRY
8 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 RESEARCH APPLICATIONS
8.2.1 CELL CYCLE ANALYSIS
8.2.2 CELL SORTING/SCREENING
8.2.3 CELL TRANSFECTION/VIABILITY
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY
8.2.4.1 DRUG DISCOVERY
8.2.4.2 STEM CELL RESEARCH
8.2.4.3 IN VITRO TOXICITY TESTING
8.2.5 IMMUNOLOGY
8.2.6 APOPTOSIS
8.2.7 CELL COUNTING
8.2.8 OTHERS
8.3 CLINICAL APPLICATIONS
8.3.1 HAEMATOLOGY
8.3.2 CANCER
8.3.3 IMMUNODEFICIENCY DISEASES
8.3.4 ORGAN TRANSPLANTATION
8.3.5 OTHER CLINICAL APPLICATION
8.4 INDUSTRIAL APPLICATIONS
9 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 HOSPITALS
9.5 CLINICAL TESTING LABORATORIES
9.6 BLOOD BANK
9.7 OTHERS
10 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 RETAIL SALES
10.3 DIRECT TENDERS
11 NORTH AMERICA FLOW CYTOMETRY MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 BD
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.2.5.1 COLLABORATION
14.3 AGILENT TECHNOLOGIES, INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 NEXCELOM BIOSCIENCE LLC
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.5.4 COMPANY SHARE ANALYSIS
14.6 APOGEE FLOW SYSTEMS LTD.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 BAY BIOSCIENCE CO., LTD.
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 BIOMÉRIEUX
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.9.4.1 ACQUISITION
14.9.4.2 PRODUCT LAUNCH
14.1 BENNUBIO INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 BIOLEGEND, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 BIO-RAD LABORATORIES, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 CELL SIGNALING TECHNOLOGY, INC.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CELLKRAFT BIOTECH PVT. LTD
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 CYTEK BIOSCIENCES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.15.3.1 PRODUCT LAUNCH
14.15.3.2 ACQUISITION
14.16 CYTOBUOY B.V.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 CYTONOME/ST, LLC
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.18 COHERENT CORP.
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.18.4.1 Announcement
14.18.4.2 PRODUCT LAUNCH
14.18.4.3 AWARDS
14.18.5 RECENT DEVELOPMENT
14.19 ELABSCIENCE BIOTECHNOLOGY INC.
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 ENZO BIOCHEM INC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENT
14.21 IKEDA SCIENTIFIC CO., LTD.
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 MERCK KGAA
14.22.1 COMPANY SNAPSHOT
14.22.2 REVENUE ANALYSIS
14.22.3 PRODUCT PORTFOLIO
14.22.4 RECENT DEVELOPMENT
14.23 MILTENYI BIOTEC
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.23.3.1 PRODUCT LAUNCH
14.24 NANOCELLECT BIOMEDICAL
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENTS
14.25 NEOGENOMICS LABORATORIES
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 ORFLO TECHNOLOGIES
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
14.28 Q2 SOLUTION
14.28.1 COMPANY SNAPSHOT
14.28.2 REVENUE ANALYSIS
14.28.3 SERVICE PORTFOLIO
14.28.4 RECENT DEVELOPMENT
14.29 SONY BIOTECHNOLOGY INC.
14.29.1 COMPANY SNAPSHOT
14.29.2 PRODUCT PORTFOLIO
14.29.3 RECENT DEVELOPMENT
14.3 STRATEDIGM, INC
14.30.1 COMPANY SNAPSHOT
14.30.2 PRODUCT PORTFOLIO
14.30.3 RECENT DEVELOPMENT
14.31 SYSMEX CORPORATION
14.31.1 COMPANY SNAPSHOT
14.31.2 REVENUE ANALYSIS
14.31.3 PRODUCT PORTFOLIO
14.31.4 RECENT DEVELOPMENT
14.32 TAKARA BIO INC.
14.32.1 COMPANY SNAPSHOT
14.32.2 REVENUE ANALYSIS
14.32.3 PRODUCT PORTFOLIO
14.32.4 RECENT DEVELOPMENTS
14.33 UNION BIOMETRICA, INC.
14.33.1 COMPANY SNAPSHOT
14.33.2 PRODUCT PORTFOLIO
14.33.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA SERVICES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA SOFTWARE IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA CELL-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA BEAD-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA INDUSTRIAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA HOSPITALS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA CLINICAL TESTING LABORATORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA BLOOD BANK IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA OTHERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA RETAIL SALES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA DIRECT TENDERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 U.S. FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 U.S. REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 U.S. FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 U.S. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 U.S. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 53 U.S. CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 54 U.S. ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 U.S. FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 56 U.S. FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 U.S. RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 58 U.S. PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 U.S. CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 60 U.S. FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 U.S. FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 CANADA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CANADA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 CANADA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 CANADA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 CANADA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 67 CANADA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 68 CANADA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 69 CANADA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 70 CANADA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 CANADA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 CANADA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 CANADA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 CANADA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 75 CANADA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 76 MEXICO FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 MEXICO REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 MEXICO FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 MEXICO CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 MEXICO CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 81 MEXICO CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 82 MEXICO ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 MEXICO FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 84 MEXICO FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 85 MEXICO RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 MEXICO PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 MEXICO CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 MEXICO FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 MEXICO FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA FLOW CYTOMETRY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA FLOW CYTOMETRY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA FLOW CYTOMETRY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA FLOW CYTOMETRY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA FLOW CYTOMETRY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA FLOW CYTOMETRY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA FLOW CYTOMETRY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA FLOW CYTOMETRY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA FLOW CYTOMETRY MARKET: SEGMENTATION
FIGURE 11 INCREASING INCIDENCE AND PREVALENCE OF CHRONIC DISEASES ARE EXPECTED TO DRIVE THE NORTH AMERICA FLOW CYTOMETRY MARKET IN THE FORECAST PERIOD
FIGURE 12 THE REAGENTS AND CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FLOW CYTOMETRY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FLOW CYTOMETRY MARKET
FIGURE 14 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, 2022
FIGURE 15 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA FLOW CYTOMETRY MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2022
FIGURE 19 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA FLOW CYTOMETRY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, 2022
FIGURE 23 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA FLOW CYTOMETRY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA FLOW CYTOMETRY MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA FLOW CYTOMETRY MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA FLOW CYTOMETRY MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA FLOW CYTOMETRY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA FLOW CYTOMETRY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA FLOW CYTOMETRY MARKET: PRODUCT (2023-2030)
FIGURE 39 NORTH AMERICA FLOW CYTOMETRY MARKET: COMPANY SHARE 2022 (%)
